Leadership

Dr. Mu Gao

Cofounder and Chief Technology Officer

Dr. Gao is at the forefront of our science-driven, AI-empowered initiatives aimed at pioneering groundbreaking therapeutic discoveries. With an unwavering commitment to pushing the boundaries of biotechnology, Dr. Gao leads our team in spearheading interdisciplinary collaboration, where emergent ideas in artificial intelligence are transformed into practical innovations to tackle biomedical challenges head-on.

Dr. Gao's expertise lies in the development and implementation of a cutting-edge deep learning-based platform for therapeutic discovery. This platform is pivotal in unraveling the molecular mechanisms of potential drug targets and designing novel therapeutics based on enhanced mechanistic understanding. His dedication to harnessing the power of AI extends beyond mere innovation; it is a commitment to addressing complex challenges and positively impacting the lives of individuals worldwide.

Prior to joining AgnistaBio, Dr. Gao held the position of senior research scientist at the Georgia Institute of Technology. There, he played pivotal roles in driving scientific discoveries aimed at understanding the intricate function and structure of biomolecules, as well as their interactions. His contributions are reflected in over fifty peer-reviewed publications in renowned scientific journals such as Nature and PNAS.

Dr. Gao's is the lead developer of several rigorously benchmarked computational approaches for predicting protein structures and functions, as well as facilitating protein sequence or structure comparison. His latest advancements, leveraging deep learning-based methods, have been deployed in leading supercomputing centers such as Summit and Perlmutter, and proteome-scale applications of these methods have made intriguing discoveries, addressing some long-existing puzzles within the field.

Dr. Gao obtained his Ph.D. from University of Illinois at Urbana-Champaign.